Explore Teva in Canada
We are all in for better health.
At Teva Canada, we make medicine so Canadians can live their lives.
We are committed to discovering, developing, and delivering innovative and biosimilar medicines, while leveraging our capabilities to bring forward complex generics at scale to help create more value for patients and healthcare systems.
For 60 years, we have proudly served the healthcare needs of Canadians. From our start in Don Mills, Toronto, we have expanded our footprint across Montreal, Markham, Stouffville, and Toronto, always ensuring to invest in the communities where we operate. We are honoured to be one of the first generic pharmaceutical companies in Canada, and we continue to lead the way in providing quality medicines.
Dedicated to strengthening Canada’s pharmaceutical industry and safeguarding the health and well-being of our communities
Teva Canada is a proud member of the Canadian Generic Pharmaceutical Association (CGPA) and the Canadian Pharmaceutical Manufacturers Exporters Alliance (CPMEA). In collaboration with CGPA and CPMEA, we advocate for Canadian pharmaceutical producers, support a strong domestic manufacturing sector, and help ensure a resilient pharmaceutical landscape in Canada.
A full spectrum of innovation
Biosimilars
Generics
Innovative therapeutic areas of focus
- Migraine and headache
- Movement disorders and neurodegeneration
- Schizophrenia
- Respiratory
Shaping a healthy future
Annual savings to the Canadian healthcare system in 2024
Our commitment to the community
Quality you can trust, made in Canada
>70% of the medicines Teva Canada sells in Canada are Made in Canada
>94% of the medicines Teva Canada makes at our Stouffville, Ontario manufacturing site are for the Canadian market
Teva Canada’s commitment to local production not only supports our economy but also ensures that Canadians have access to the medications they need.
Explore our manufacturing facilitiesSocial and economic impact around the world
*Health Partners International of Canada
Download our facts & figures one-pager
NPS-CA-NP-01071, 09/2025